Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237872 · ClinicalTrials.gov registry record
Detection of Brown Adipose Tissue by Magnetic Resonance Imaging
A clinical trial of Obesity and Brown Adipose Tissue, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 8
- Enrollment target
- 2
- Study locations
NCT02237872: Completed study of Obesity and Brown Adipose Tissue, sponsored by University of North Carolina, Chapel Hill.
NCT02237872 is a study of Obesity and Brown Adipose Tissue that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 8 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02237872, a study of Obesity and Brown Adipose Tissue, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary goal of this study is to assess the accuracy of conventional fat fraction proton MRI for the detection of Brown Adipose Tissue (BAT) in healthy subjects using \[18F\]-2-fluoro-2-deoxy-D-glucose (fluorodeoxyglucose) -PET as gold standard. In this pilot study, MRI and PET imaging of BAT of healthy adult volunteers will be performed on a combined PET/MRI scanner under mild cold condition.
Primary Outcome
The average dice similarity coefficient will be measured to assess the overlap between MRI and PET maps
Conditions Studied
Study Locations (2)
North Carolina
- Biomedical Research Imaging Center - Chapel Hill
- Biomedical Research Imaging Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-01-20 |
| Est. Completion | 2015-08-27 |
What the finished NCT02237872 record still lists
NCT02237872 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02237872 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02237872 about?
NCT02237872 is a clinical study titled "Detection of Brown Adipose Tissue by Magnetic Resonance Imaging". The primary goal of this study is to assess the accuracy of conventional fat fraction proton MRI for the detection of Brown Adipose Tissue (BAT) in healthy subjects using \[18F\]-2-fluoro-2-deoxy-D-glucose (fluorodeoxyglucose) -PET as gold standard. In this pilot study, MRI and PET imaging of BAT o...
What is the current status of trial NCT02237872?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2015-01-20. Estimated completion is 2015-08-27.
What conditions does trial NCT02237872 study?
This clinical trial studies the following conditions: Obesity, Brown Adipose Tissue.
Who is sponsoring clinical trial NCT02237872?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02237872 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02237872's enrollment target sits among peer trials
8 1038th of 1053 higher than 10 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI